Dysphagia, Neuro-Degenerative Disease, Swallowing Disorder
Conditions
Brief summary
The English version of the "Clinical Assessment of Dysphagia in Neurodegeneration" (CADN), represents a rapid and valid clinical assessment tool for dysphagia in neurodegenerative population. Currently, there is no validated tool in Italian specific for the clinical assessment of dysphagia in neurodegenerative disease with strong psychometric characteristics. The present study aims to translate and validate the Italian version of CADN in neurodegenerative population. Psychometric properties will be measured.
Detailed description
Most of patients with a neurodegenerative disease will develop swallowing impairments (dysphagia) during their disease progression (up to 80%- 100% in Parkinson disease and Amyotrophic Lateral Sclerosis). Dysphagia is associated with serious clinical complications, particularly regarding loss of life quality, insufficient medication intake, malnutrition, dehydration, and aspiration with subsequent pneumonia, which is the leading cause of death in this population. Early detection and measurement of dysphagia trough validated and standardized procedures plays a fundamental role in the clinical practice. Clinical assessment by a speech language pathologist (SLP) can provide early identification of dysphagia and its severity and direct clinical decision making. The English version of the "Clinical Assessment of Dysphagia in Neurodegeneration" (CADN), represents a rapid and valid clinical assessment tool for dysphagia in neurodegenerative population. Currently, there is no validated tool in Italian specific for the clinical assessment of dysphagia in neurodegenerative disease with strong psychometric characteristics. The present study aims to translate and validate the Italian version of CADN in neurodegenerative population. The study will be carried out in two phases: 1. Forward and back translation 2. Validation process
Interventions
OTHERAdministration of Clinical Assessment of Dysphagia in Neurodegeneration (CADN)
the CADN will be administrated to each patient at the enrolment
Sponsors
Istituti Clinici Scientifici Maugeri SpA
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* diagnosis of neurodegenerative disease according to the respective consensus criteria * \>18 years old * able to provide informed consent * able to follow simple instructions * capable of sitting upright for anamnesis and examination for at least 20 min (in chair or wheelchair)
Exclusion criteria
* history of stroke * surgery to the head or neck * radiotherapy in the last 12 months * dysphagia resulting from other known causes
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Clinical Assessment of Dysphagia in Neurodegeneration (CADN) | at the enrolment | Clinical assessment tool administrated by a Speech Language Pathologist. The CADN is composed by a clinical case history and a consumption part for a total of 11 item. Severity scores for each item range from 0 (no impairment) to 4 (severe impairment). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Fiberoptic Endoscopic Evaluation of Swallowing (FEES) | At the enrolment | Instrumental examination, gold standard for the assessment of dysphagia. |
Countries
Italy
Outcome results
None listed